Invention Grant
- Patent Title: Vectors for molecule delivery to CD11b expressing cells
-
Application No.: US15177029Application Date: 2016-06-08
-
Publication No.: US10004794B2Publication Date: 2018-06-26
- Inventor: Claude LeClerc , Pierre Guermonprez , Daniel Ladant , Nicole Guiso , Nadia Khelef , Cecile Bauche , Catherine Fayolle , Mohammed El-Azami El-Idrissi
- Applicant: INSTITUT PASTEUR , CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
- Applicant Address: FR Paris FR Paris
- Assignee: INSTITUT PASTEUR,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
- Current Assignee: INSTITUT PASTEUR,CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
- Current Assignee Address: FR Paris FR Paris
- Agency: Arrigo, Lee, Guttman & Mouta-Bellum LLP
- Priority: EP00402562 20000915
- Main IPC: A61K39/02
- IPC: A61K39/02 ; A61K39/385 ; C12N9/88 ; C12N15/85 ; A61K47/64 ; A61K39/00
Abstract:
The invention relates to a novel use of a Bordetella adenylcyclase toxin in the manufacturing of vectors for targeting in vivo a molecule of interest, specifically to CD11b expressing cells. The invention also relates to an immunogenic composition that primes immune responses, to pharmaceutical compositions and to a new vector for molecule delivery to CD11b expressing cells.
Public/Granted literature
- US20160375119A1 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS Public/Granted day:2016-12-29
Information query
